Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Joel Latham
Recent news which mentions Joel Latham
Fortrea To Manage Incannex's FDA IND Opening Phase 2/3 Trial Of Its Dronabinol-Based Drug For Obstructive Sleep Apnea
July 18, 2023
Tickers
FTRE
IXHL
Tags
Benzinga
News
premium
From
Benzinga
Incannex Stock Trading Higher On Entering A Lease For First Psychedelic-Assisted Psychotherapy Clinic
May 05, 2023
Tickers
IXHL
Tags
Joel Latham
Markets
Psychedelics
From
Benzinga
Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials
March 03, 2023
Tickers
CTLT
IXHL
Tags
premium
News
CTLT
From
Benzinga
Incannex Healthcare To Acquire APIRx Pharmaceuticals For $93.3M
March 24, 2022
Tickers
IXHL
Tags
Benzinga
News
Markets
From
Benzinga
Psychedelics And Virtual Reality Treatment Developed By Monash University, Funded By Incannex
March 03, 2022
Tickers
IXHL
Tags
News
Suresh Sundram
Benzinga
From
Benzinga
Medicinal Cannabis And Psychedelics Company Incannex Lists American Depositary Shares On Nasdaq
February 28, 2022
Tickers
IXHL
Tags
Cannabis
Market News
Deutsche Bank Trust Company Americas
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.